BioSpace News Archive

According to Vision Research Reports, the global primary immunodeficiency market size surpassed at US$ 6.56 Bn in 2021 and is expected to grow at a CAGR of 6.2% from 2022 to 2030.

ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today that Company leadership will participate in two upcoming investor conferences.

The global attention deficit hyperactivity disorder market size was valued at US$ 17.4 billion in 2020 and is anticipated to grow at a CAGR of 7.4% during forecast period 2022 to 2030.

According to Vision Research Reports, the global respiratory disorders treatment market size surpassed at US$ 73.11 Bn in 2021 and is projected to grow at a CAGR of 6.2% from 2022 to 2030.

Biological Dynamics, an exosome-isolation technology and early disease detection diagnostic company, today announced that it has partnered with both QURE Healthcare and Curta to explore how the company’s assay for early detection of pancreatic ductal adenocarcinoma (PDAC) can improve patient outcomes, demonstrate the greatest value to clinicians, and enhance healthcare economics.

Ulrich Steidl, M.D., Ph.D., an internationally recognized leader in cancer and stem cell biology, has been named the chair of the department of cell biology at Albert Einstein College of Medicine.

Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in oncology, neurology, and virology announced today its intention to study potential therapeutic use of its investigational COVID-19 T cell therapy, TVGN-489, in Long COVID.

According to Nova one advisor, the global Stomach Cancer Treatment Market Size accounted for USD 4.83 Billion in 2022 and is estimated to achieve a market size of USD 15.2 Billion by 2030 growing at a CAGR of 14.9% from 2022 to 2030.

Hyperfine announced that the company will be participating in the upcoming 5th Annual Evercore ISI HealthCONx Conference.

Tempest Therapeutics, Inc. announced that management will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on Tuesday, November 29, 2022 at 11:30 am ET.